Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CONCORD BIOTECH Gains 7%; BSE HEALTHCARE Index Up 0.2%
Thu, 17 Oct 9:28

CONCORD BIOTECH Gains 7%; BSE HEALTHCARE Index Up 0.2%Image source: alexsl/www.istockphoto.com

CONCORD BIOTECH share price has zoomed 7% and is presently trading at Rs 2,117.3.

Meanwhile, the BSE HEALTHCARE index is at 44,741.0 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are Pfizer (up 2.2%) and ALKEM LABORATORIES (up 1.3%).

Torrent Pharma (down 0.9%) and ALEMBIC PHARMA (down 0.9%) are among the top losers today.

Over the last one year, CONCORD BIOTECH has moved up from Rs 1,189.8 to Rs 2,117.3, registering a gain of Rs 927.5 (up 78.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,166.2 to 44,741.0, registering a gain of 58.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 200.3%), Glenmark Pharma (up 122.6%) and SUVEN PHARMACEUTICALS (up 114.1%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,526.2 .

The top gainers among the BSE Sensex today are L&T (up 1.1%) and Infosys (up 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,940.2 (down 0.1%). Bajaj Auto and Hero Motocorp are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,166.9 to 81,526.2, registering a gain of 15,359.3 points (up 23.2%).

CONCORD BIOTECH Financial Update...

CONCORD BIOTECH net profit grew 20.2% YoY to Rs 582 million for the quarter ended June 2024, compared to a profit of Rs 485 million a year ago. Net sales rose 10.8% to Rs 2,158 million during the period as against Rs 1,948 million in April-June 2023.

For the year ended March 2024, CONCORD BIOTECH reported 28.3% increase in net profit to Rs 3,081 million compared to net profit of Rs 2,401 million during FY23. Revenue of the company grew 19.2% to Rs 10,169 million during FY24.

The current Price to earnings ratio of CONCORD BIOTECH, based on rolling 12 month earnings, stands at 70.4.


Equitymaster requests your view! Post a comment on "CONCORD BIOTECH Gains 7%; BSE HEALTHCARE Index Up 0.2%". Click here!